About Us

Co-Founder and Chief Technology Officer

Martin holds a B. Eng. from McGill University and both a Master’s and a Doctorate in Aeronautics from the California Institute of Technology. He is currently a Professor in the Mechanical Engineering Department at the Université de Sherbrooke in Canada where he heads the Shock Wave Research Laboratory. Martin is the originator of several technology development projects in bio-engineering and micro-engineering, based on gas dynamics and shock wave physics. He is the holder of numerous patents for biomedical devices and sensor systems for aerospace applications and at the origin of three start-ups exploiting these technologies. He has held several leadership positions with Soundbite Medical and currently serves as Chief Technology Officer.

Co-Founder and Director, Consumables

Louis-Philippe holds a B. Eng, Master’s and Doctorate in Mechanical Engineering from the University of Sherbrooke. As co-founder of Soundbite Medical, he developed the core crossing technology for the company. He has held various leadership positions within the company and current serves as Director of Product Development for the Disposables & Systems. Louis-Philippe is the co-inventor of numerous patents related to the Soundbite technology and authored or co-authored numerous publications.

Co-Founder and Director, Console Operations

Steven holds a Doctorate in Mechanical Engineering from the Université de Sherbrooke where he developed a device for the non-invasive treatment of kidney stones. In parallel, he worked to adapt the technology for the cardiovascular space and founded Soundbite. His patented invention is the core technology driving Soundbite Medical products. He and his team have developed the first three generations of the Soundbite shock wave generator (the Console) and he is listed as an inventor on most of Soundbite’s patents. Earlier in his career, Steven worked at the LOCUS research laboratory (Université de Sherbrooke) where he did research and development on other patented medical devices such as a needle-less injector.

Co-Founder

Currently the MedTech Entrepreneur-in-Residence at Centech, Steve has directed and created several medical device companies, from inception to major financing and public stock offerings, in addition to advancing new medical devices from R&D to commercialization and global sales marketing. He served as CEO for Soundbite from inception until 2017. He has also served as CEO for a number of companies, most notably CryoCath Technologies (sold to Medtronic Inc. for $400 million CAD), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for $100 million USD). Steve is also an angel investor in medical technology and is involved in mentorship and teaching of graduate students at McGill University and Concordia University interested in developing medical technology.

President and CEO

Thomas Little, CPA, ICD.D., is an accomplished executive with over 39 years of experience leading transformational change across organizations. Mr. Little served as the Executive Vice President of Bell Canada and President of Bell Business Markets, where he successfully implemented strategies to enhance the client experience by integrating wireless and wireline business groups and transforming the client experience. Prior to that, he helped build and operate successful Canadian technology companies, including as the President and CEO of VisualSonics Inc. and as EVP and GM at DICOM Information Technologies, both of which yielded successful liquidity events. Mr. Little is a Chartered Professional Accountant and holds an Honours Business Administration degree from the IVEY School of Business at the University of Western Ontario. Additionally, he has obtained an ICD.D. designation from the Rotman Directors Education Program. He is currently a director at AIMIA, Rise Asset Development, Soundbite Medical Solutions and an advisory board member of Curait Medical.

Vice President, Product Development

Matt Olson has over twenty-three years of experience in the medical device industry, with seventeen of those years in leadership roles at successful emerging technology companies. He has held roles in R&D, Operations, Manufacturing, and Clinical Training across the span of his career. Most recently, Matt was the Vice-President of Engineering & Operations at NexGen Medical Systems. He also served as Vice-President of Research & Development at Bridgepoint Medical when acquired by Boston Scientific and Medtronic in 2012, and was Director of Operations at Teramed, acquired by Johnson & Johnson in 2001. Additionally, he has held several management positions at American Medical Systems (AMS) and Boston Scientific. Matt is listed as an inventor on twenty-two medical device patents. He holds a Bachelor of Science degree in Mechanical Engineering from North Dakota State University.

Vice President, Marketing

Mrs. Suzanne Wallace has more than 10 years of experience with medical devices in various roles across marketing, education, and medical affairs. Previously, she served as Senior Director of Clinical Marketing for Vesper Medical overseeing all marketing activities for the pre-commercial start-up company based in Pennsylvania. Prior to that, Suzanne was the Director of Medical Education and Scientific Communications at Shockwave Medical where she had dual medical affairs and marketing responsibilities for their global portfolio of products. Earlier in her career, Mrs. Wallace was the Director of Field Marketing and Education in Medtronic’s Mechanical Circulatory Support Business (Heartware, Inc.) where she was responsible for all aspects of commercial marketing and customer training programs. Mrs. Wallace is a board-certified Nurse Practitioner with a post-master’s degree in family practice and a Master of Science in nursing with a specialization in emergency and critical care. She spent the majority of her clinical career at the Penn State Hershey Medical Center caring for patients with cardiovascular disease. She received her B.S.N. from Messiah College and both her M.S.N. and post-master’s certificate from Widener University. She is cited as author or co-author in more than 10 publications.

Vice President, Clinical Development

John has over thirty years of clinical trial experience with products ranging from implantable insulin pumps and blood gas monitors, to a variety of interventional products used in peripheral vascular, cardiovascular, and electrophysiology procedures. He has held roles in clinical executive management and clinical project management across several emerging technology companies, many of which were successfully acquired. These include MiniMed Technologies (Medtronic), EndiCOR Medical (ev3/Medtronic), Endocardial Solutions (St. Jude Medical/Abbott), and BridgePoint Medical (Medtronic & Boston Scientific). John brings extensive experience in electrophysiology, as well as percutaneous interventional procedures, including thrombectomy and chronic total occlusion treatment in the cardiovascular, neurovascular and peripheral vascular settings. John is listed as an inventor on two U.S. patents, and is cited as an author or co-author on nine publications. He holds a Bachelor of Science in Biomedical Engineering from the University of Southern California.